This practice in the health insurance industry may have ‘gotten out of control,’ Wall Street analyst says

Jason MaBy Jason MaWeekend Editor
Jason MaWeekend Editor

    Jason Ma is the weekend editor at Fortune, where he covers markets, the economy, finance, and housing.

    Getty Images
    • Some people think using artificial intelligence for so-called “prior authorizations” in the healthcare industry has become too excessive, fuelling public anger at insurance companies. “That’s where I think there should be a healthy debate because maybe that has gotten out of control,” said John Ransom, director of healthcare research at Raymond James.

    Health insurance stocks jumped after Donald Trump won the presidential election on expectations for deregulation in the industry, but shares tumbled after the killing of UnitedHealthcare CEO Brian Thompson.

    In UnitedHealth’s case, the stock surged as much as 9% in the immediate aftermath of the election, but has sold off 15% since Dec. 4.

    Even with Republicans poised for unified control of Congress and the White House, the pre-election narrative on insurers now looks shakier, John Ransom, director of healthcare research at Raymond James, told CNBC on Tuesday.

    “I think the bet is a little bit hard to make because you don’t know who’s going to be occupying these seats,” he said. “And also, you do have a more populist party, and the industry is not as popular as it used to be.”

    In fact, Thompson’s shooting unleashed a wave of online vitriol aimed at insurers over coverage that was denied to patients. Meanwhile, security firms have been flooded with calls from companies looking to ramp up protection for executives.

    UnitedHealth Group CEO Andrew Witty addressed the criticism of his company in a New York Times op-ed on Friday and acknowledged the healthcare system needs improvement.

    But the industry still faces a “legislative risk,” Ransom said, amid a debate on the use of artificial intelligence in so-called prior authorizations, which is when a service or prescription requires pre-approval from companies.

    “That’s where I think there should be a healthy debate because maybe that has gotten out of control,” he added. 

    AI can still make a positive impact on healthcare, Ransom said. For example, large language models could be used to analyze difference datasets to help predict who might need services and intervene before a situation turns into a health crisis.

    “But yeah, did we overdo it on prior auth?” he asked. “That’s the debate. I’m not saying we did, but I think that’s where we need to have a debate.”

    Fortune Global Forum returns Oct. 26–27, 2025 in Riyadh. CEOs and global leaders will gather for a dynamic, invitation-only event shaping the future of business. Apply for an invitation.